Not a good buy right now for an impatient entry: price (~56.6 pre-market) is pressing into near-term resistance (R2 ~56.894) while momentum is extremely overbought (RSI_6 ~88), which skews the near-term risk toward a pullback.
The earnings beat and revenue growth are positives, but the CEO resignation is an uncertainty catalyst that can cap upside short-term.
Trend is bullish: SMA_5 > SMA_20 > SMA_200 confirms an uptrend.
MACD histogram is positive and expanding (0.583), supporting continued bullish momentum.
However, RSI_6 at ~88 indicates a very overbought condition; chasing here has poorer immediate reward/risk.
Price is near key resistance: R2 ~56.894 (pre-market ~56.6). If it fails to break and hold above, a mean-reversion dip is likely.
Key levels: Pivot ~51.969 (major near-term mean level), Support S1 ~48.924; Resistance R1 ~55.013 (already cleared) and R2 ~56.894.
Pattern-based forward bias provided: +0.61% next day probability edge, but -3.23% next week (near-term pullback risk dominates).
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Open Interest Put/Call Ratio 1.09: slightly put-skewed positioning (mildly cautious/defensive sentiment).
Option volume is effectively zero in the snapshot (Put-Call Volume Ratio 0.0), so real-time sentiment from flow is weak/less reliable.
Implied vol (30D) ~50.9 vs historical vol ~42.8 suggests options are pricing elevated movement.
IV percentile ~43 and IV rank ~13: not an extreme IV regime; not clearly screaming panic or euphoria.
Technical Summary
Sell
4
Buy
10
Positive Catalysts
and delivered revenue growth ($704M, +7% YoY).
Institutional/insider posture is neutral (no notable selling pressure indicated).
Neutral/Negative Catalysts
Technicals are stretched: RSI_6 88 and price is near R2 resistance (56.894), increasing odds of a near-term fade.
CEO Jeff Benck resignation introduces leadership/transition uncertainty right after earnings.
Financial snapshot shows GAAP net income and EPS as down -100% YoY (reported as 0 in the snapshot), which can weigh on headline perception even if non-GAAP was solid.
Similar-pattern stats indicate downside risk over the next week (-3.23%).
Profitability quality is mixed: gross margin improved to 10.36 (+1.97% YoY), but the snapshot shows net income and EPS at 0 (down -100% YoY), while news highlights non-GAAP EPS of $0.71 (suggesting GAAP/non-GAAP divergence).
Takeaway: operations/revenue trend looks better than GAAP bottom-line optics; market may focus on whichever metric dominates headlines.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent change (2026-01-23): Lake Street raised price target to $57 from $51 and maintained Buy.
Wall Street pro view (pros): exposure to A&D/AI/Medical growth, expected semi order ramp through 2026, improving margins.
Wall Street pro view (cons): near-term execution/transition risk after CEO resignation, and mixed GAAP earnings optics in the latest quarter snapshot.
Overall: analysts are incrementally more positive, but the stock’s current technical stretch makes the timing unattractive for a buy right now.
Wall Street analysts forecast BHE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BHE is 49 USD with a low forecast of 47 USD and a high forecast of 51 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast BHE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BHE is 49 USD with a low forecast of 47 USD and a high forecast of 51 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 56.010
Low
47
Averages
49
High
51
Current: 56.010
Low
47
Averages
49
High
51
Needham
James Ricchiuti
Buy
maintain
$55 -> $62
AI Analysis
2026-02-04
New
Reason
Needham
James Ricchiuti
Price Target
$55 -> $62
AI Analysis
2026-02-04
New
maintain
Buy
Reason
Needham analyst James Ricchiuti raised the firm's price target on Benchmark Electronics to $62 from $55 and keeps a Buy rating on the shares. The company posted better-than-expected Q4 results and provided a solid Q1 outlook as Benchmark prepares for an orderly transition to a new CEO in early 2026 against a backdrop of improving end market demand, the analyst tells investors in a research note.
Lake Street
Max Michaelis
Buy
maintain
$57 -> $62
2026-02-04
New
Reason
Lake Street
Max Michaelis
Price Target
$57 -> $62
2026-02-04
New
maintain
Buy
Reason
Lake Street analyst Max Michaelis raised the firm's price target on Benchmark Electronics to $62 from $57 and keeps a Buy rating on the shares after the company reported "strong" Q4 results. The firm believes the stock "should continue to melt higher" as the company shows progress of a semi cap return and further strength from its other key end markets, the analyst tells investors.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BHE
